Re:Early treatment of Covid-19 with HCQ and AZ:retrospective...
by klmadfejno on Wednesday May 06, 2020 @11:43AM
(#23092298)
> I'm confident that has to do with top of funnel.
I think you're probably correct. But, frustratingly, it's equally possible that the HCQ increased the likelihood of negative outcomes for younger patients. Or, that HCQ decreased the likelihood of negative outcomes without regard to age, resulting in fewer bad outcomes for really old people.
Re:Early treatment of Covid-19 with HCQ and AZ:retrospective...
by arcticbull on Wednesday May 06, 2020 @11:47AM
(#23092362)
Ahh I see what you're saying. That's a really good point.
sigh COVID-19 is associated with low fatality rate in patients. It's not clear this combination of drugs does anything other than not kill people any faster.
> As an aside, I do feel like the mean age of poor clinical outcomes, 69, feels a bit low relative to my expectations.
I'm confident that has to do with top of funnel.